Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN")
Relevance. Interpretation of the preclinical trials data is fundamental importance. The correctness of extrapolation of data obtained from animals to humans is due to the qualitative and quantitative diversity of the systems tested the recorded parameters and approaches to their interpretation, as w...
Saved in:
| Main Authors: | V. B. Vasilyuk, M. V. Faraponova, G. I. Syraeva, A. B. Verveda, A. V. Belskaya, A. V. Shults, L. G. Kubarskaya, E. A. Zolotoverkhaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2022-12-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reamberin in Tuberculosis Chemotherapy and Its Effect on Liver Function
by: I. S. Gelberg, et al.
Published: (2020-05-01) -
The influence of reamberin on oxygen balance, oxidative stress and lung dysfunction in patients with abdominal sepsis
by: A. B. Tolkach, et al.
Published: (2012-06-01) -
Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters
by: V. B. Vasilyuk, et al.
Published: (2024-06-01) -
Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
by: L. V. Nowicka-Usenko, et al.
Published: (2016-10-01) -
Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination
by: V. M. Frolov, et al.
Published: (2020-05-01)